drugset

drugset / Trial / NCT00115310

Study of NGX-4010 for the Treatment of Postherpetic Neuralgia

NCT00115310 ↗

Phase 3 Completed 400 enrolled NeurogesX

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the study is to assess the efficacy and safety of NGX-4010 applied for 60 minutes for the treatment of postherpetic neuralgia (PHN).

Timeline

Start: 2005-06
Primary completion: —
Completion: 2006-10

Publications

Backonja M, Wallace MS, Blonsky ER, Cutler BJ, Malan P Jr, Rauck R, Tobias J; NGX-4010 C116 Study Group. NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study. Lancet Neurol. 2008 Dec;7(12):1106-12. doi: 10.1016/S1474-4422(08)70228-X. Epub 2008 Oct 30.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Capsaicin	Small molecule	8 %	Topical

Indications